EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multidrug-Resistant Acinetobacter baumannii: Resistance Mechanisms, Emerging Therapies, and Prevention—A Narrative Review

Ioana Adelina Stoian, Bianca Balas Maftei, Carmen-Elena Florea, Alexandra Rotaru, Constantin Aleodor Costin iD, Maria Antoanela Pasare, Radu Crisan Dabija iD, Carmen Manciuc

Antibiotics · 19.12.2025 · 15 (1) · 2

DOI: 10.3390/antibiotics15010002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 19.12.2025. Verfasst von Ioana Adelina Stoian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii is a leading intensive care unit (ICU) pathogen associated with high rates of carbapenem resistance and poor clinical outcomes. This narrative review synthesizes recent clinical, microbiological, and pharmacokinetic/pharmacodynamic (PK/PD) evidence regarding resistance mechanisms and therapeutic strategies. A literature review was performed in PubMed, Scopus, and Web of Science (January 2015–August 2025), focusing on multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, ICU-acquired infections, and pivotal trials involving cefiderocol and sulbactam–durlobactam. Resistance is driven by OXA-type carbapenemases (notably OXA-23/24/58), efflux systems (AdeABC/IJK/FGH), porin alterations (CarO, Omp33–36), and lipopolysaccharide (LPS) modifications conferring colistin resistance. Management options include polymyxins, optimized tigecycline dosing, β-lactam/β-lactamase inhibitors, and newer agents such as cefiderocol and sulbactam–durlobactam, though mortality and safety outcomes vary across trials. A comparative table is included, summarizing antimicrobial mechanism coverage, PK/PD parameters, and adverse effects to support regimen selection in ventilator-associated pneumonia (VAP) and bacteremia. Optimized, multimodal approaches integrating timely diagnostics, targeted combination therapies, infection prevention, and antimicrobial stewardship are essential to improve outcomes and limit the spread of MDR and XDR A. baumannii.

Schlagwörter

Stichwörter der Autor:innen

Acinetobacter baumanniiICU infectionsOXA carbapenemasesantimicrobial therapycarbapenem resistancecefiderocolextensively drug-resistantmultidrug resistancesulbactam–durlobactam

Autor:innen und Institutionen

  • Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Clinical Hospital of Pneumology, 700115 Iasi, Romania.
  • "Sfânta Parascheva" Clinical Hospital for Infectious Diseases, 700116 Iasi, Romania.

ORCID-Profile: Constantin Aleodor Costin, Radu Crisan Dabija

Zitieren

APA

Stoian, I. A., Balas Maftei, B., Florea, C. E., Rotaru, A., Costin, C. A., Pasare, M. A., Crisan Dabija, R., & Manciuc, C. (2025). Multidrug-Resistant Acinetobacter baumannii: Resistance Mechanisms, Emerging Therapies, and Prevention—A Narrative Review. Antibiotics, 15(1), 2. https://doi.org/10.3390/antibiotics15010002

Vancouver

Stoian IA, Balas Maftei B, Florea CE, Rotaru A, Costin CA, Pasare MA, et al. Multidrug-Resistant Acinetobacter baumannii: Resistance Mechanisms, Emerging Therapies, and Prevention—A Narrative Review. Antibiotics. 2025;15(1):2. doi:10.3390/antibiotics15010002

BibTeX
@article{Stoian2025,
  author = {Stoian, Ioana Adelina and Balas Maftei, Bianca and Florea, Carmen-Elena and Rotaru, Alexandra and Costin, Constantin Aleodor and Pasare, Maria Antoanela and Crisan Dabija, Radu and Manciuc, Carmen},
  title = {Multidrug-Resistant Acinetobacter baumannii: Resistance Mechanisms, Emerging Therapies, and Prevention—A Narrative Review},
  journal = {Antibiotics},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {2},
  doi = {10.3390/antibiotics15010002}
}
Kostenlos starten →